HomeIVBXF • OTCMKTS
add
Innovent Biologics Inc
Previous close
$12.72
Day range
$12.75 - $12.75
Year range
$3.91 - $15.12
Market cap
167.59B HKD
Avg Volume
86.63K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.98B | 50.62% |
Operating expense | 1.91B | 16.28% |
Net income | 417.16M | 312.50% |
Net profit margin | 14.01 | 241.09% |
Earnings per share | — | — |
EBITDA | 446.16M | 458.56% |
Effective tax rate | 7.00% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.54B | 10.56% |
Total assets | 23.59B | 16.25% |
Total liabilities | 9.17B | 16.56% |
Total equity | 14.42B | — |
Shares outstanding | 1.64B | — |
Price to book | 1.45 | — |
Return on assets | 3.93% | — |
Return on capital | 5.21% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 417.16M | 312.50% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
Apr 28, 2011
Website
Employees
6,190
